{"prompt": "['Date: June 30, 2020', 'Version: 8.0', 'Page: 33 of 52', 'Urine Drug Screen', 'X', 'Urine Pregnancy8', '--', 'X', 'X', 'X', 'X', 'Patient Reported', 'Outcomes (REDCap)', 'Diary Dispensing or', 'X', '--', '--', '--', '--', 'X', 'Return9', 'Diary Compliance10', '--', 'X', 'X', 'X', 'X', 'X', 'EQ-5D-5L QoL', '--', '--', 'X', '--', '--', 'X', 'Questionnaire11', 'Stool Samples 12', 'Bacteria (16S rRNA)', '--', 'X', '--', '--', 'X', 'Methanogens (qPCR)', '--', 'X', '--', '--', 'X', '--', 'Breath Gases', 'Lactulose breath test13', 'X', '--', '--', 'X', 'Single-point breath test', '--', '--', 'X', 'X', 'X', '--', '1Informed consent, inclusion/exclusion criteria, and ROME IV may be reviewed and signed prior to Visit 1.', '2Date of birth, gender, race/ethnicity.', '3Patients will complete the information in the REDCap system during the Screening Period.', '4Patients will be eligible for randomization if they fully respond to the PRO questions on at least 11 of 14 days.', '5General examination, including head, ears, eyes, nose, throat, endocrine, cardiovascular, respiratory, abdomen,', 'skin, neurological, extremities, and musculoskeletal features.', '6Body weight, blood pressure (requires the patient to be semi-supine for at least 5 minutes prior to the test) height', '(Screening Visit only), radial pulse rate, respiratory rate, and temperature.', '712-lead ECG requires the participant to be supine for at least 5 minutes prior to the test.', '8All female participants of child-bearing potential.', '9Provide and train the patient to use the REDCap system with questionnaire.', '10ngoing review and confirmation of patient PRO questionnaire compliance. Patients will complete the', 'information contained in the REDCap system each day, assessing stool frequency, SBMs, CSBMs, and use of rescue', 'medication or other laxative use; stool consistency using the Bristol Stool Chart; abdominal pain assessment using', 'visual NRS scale (0-10) and visual Likert scale (0-4) for straining and bloating assessment. Questionnaires will also', 'be completed weekly for the PAC-SYM questionnaire and Adequate Relief question.', '11EQ-5D-5L questionnaire will be completed in the REDCap system on Day 1 prior to study drug administration and', 'at Week 12 or upon early termination.', '12Pre-treatment stool sample can be collected any time during the week preceding and including Day 1 and will', 'only be analyzed if the patient is randomized into the study; Day 84 stool sample can be collected any time during', 'the week preceding and including Day 84.']['Date: June 30, 2020', 'Version: 8.0', 'Page: 34 of 52', '13 Patients are fasted overnight prior to lactulose breath testing. Lactulose breath test measures hydrogen,', 'methane, hydrogen sulfide, and carbon dioxide levels.', '9.2', 'Timing of assessments', 'Screening', 'Treatment Period', 'EOS', 'Pretreatment', 'SYN-010 42 mg q.d. (n=50)', 'SYN-010: 21 mg q.d. (n=50)', 'Placebo q.d. (n=50)', '00', 'T', '-14', '1', '14', '28', '42', '56', '70', '84', 'Screen', 'Randomize', 'DAY', 'Clinic Visits', 'Breath gases', 'Cytokines in plasma', 'Stool samples for microbiome', '9.3', 'Assessment parameters', 'Subjects who provide written consent to participate will be screened for inclusion in the study.', 'Consent to participate must be obtained prior to completing any study procedures and may be', 'obtained prior to the Screening Visit.', '9.3.1', 'ROME IV criteria', 'The investigator or designee will assess whether the subject meets the following ROME IV IBS', 'criteria28:', 'Subject has had IBS symptoms at least six months prior to diagnosis and is experiencing', 'abdominal pain, on average, at least one day per week for the three months preceding the', 'Screening Visit and associated with two or more of the following:', 'Abdominal pain or discomfort related to defecation;', 'Abdominal pain or discomfort associated with a change in frequency of stool; and/or', 'Abdominal pain or discomfort associated with a change in form (appearance) of stool.', 'On symptomatic days, subject reports more than 25% of stools are Type 1 or 2 and less than', '25% of stools are Type 6 or 7 on the Bristol Stool Form Scale.', 'In addition to the ROME IV criteria, subjects must meet the inclusion and exclusion criteria listed', 'above.']\n\n###\n\n", "completion": "END"}